Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|89|2|47-52

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.2, 2015-0, pp. : 47-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Substaging of intermediate hepatocellular carcinoma

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 358-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite

Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 19-26

Karger

Access to resources Recommend Favorite

When to perform hepatic resection for intermediate‐stage hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 905-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade

By  

Oncology, Vol. 91, Iss. 3, 2016-07 ,pp. : 153-161

Karger

Access to resources Recommend Favorite